Fact Meets Function

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function.

This peer-reviewed study demonstrates that adjunctive thymosin beta-4 (TB4) combined with standard antibiotic therapy (ciprofloxacin) not only reduces bacterial keratitis severity and accelerates wound healing, but critically also promotes corneal nerve regeneration and restores visual function—outcomes that represent significant clinical advantages beyond infection control alone. The research fills a previously unexplored gap by quantifying TB4’s impact on two often-neglected but essential determinants of long-term patient outcomes: sensory nerve recovery and functional vision restoration. For practitioners, this represents compelling evidence that TB4 adjunctive therapy addresses the full spectrum of corneal infection recovery, not just pathogen elimination.

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function. Read Post »

Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.

A peer-reviewed clinical review published in Integr Med examines peptide therapeutics—including BPC-157, thymosin alpha-1, thymosin beta-4, and growth hormone secretagogues—as potential adjunctive treatments for autoimmune thyroid disorders like Hashimoto’s that persist despite hormone normalization. The review acknowledges mechanistic rationale for peptide effects on immune signaling, inflammation, and tissue repair, but emphasizes that current evidence is primarily preclinical and exploratory, with no large randomized thyroid-specific trials yet completed. The authors call for rigorous clinical investigation to establish safety and efficacy, noting substantial evidence gaps and that peptide use in thyroid care remains investigational.

Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation. Read Post »

Thymosin beta 4: An emerging therapeutic candidate for kidney diseases.

This research review examines TB4-Fragment’s potential for treating kidney disease. The peptide shows promise in protecting kidney cells, reducing inflammation, and preventing harmful scarring in both acute and chronic kidney injuries. While the results are encouraging across multiple studies, researchers note that peptide stability and delivery remain key challenges for practical clinical use.

Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Read Post »

Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement.

Research Summary

This human clinical study investigated plasma thymosin beta-4 (Tβ4) levels in chronic ischemic heart failure patients who received intracardiac cell therapy and found that increased plasma Tβ4 was associated with symptomatic improvement in these patients. The research suggests a potential biomarker relationship between Tβ4 elevation and clinical outcomes following cell-based cardiac intervention. This is human clinical-level evidence examining the mechanistic relationship between a circulating peptide and therapeutic response in heart failure patients.

Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement. Read Post »

Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia.

Researchers analyzed serum peptide profiles in pregnant women to identify peptide biomarkers that could distinguish preeclampsia cases from normal pregnancies, utilizing peptidomic techniques to characterize protein fragments circulating in blood samples. The study identified specific peptide signatures, including TB4-Fragment, that showed potential diagnostic value for preeclampsia detection. This evidence comes from human clinical studies analyzing biomarker patterns in patient serum samples.

Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. Read Post »

[Thymic hormones. Neuroendocrine interactions and clinical use in congenital and acquired immune deficiencies].

This review examined thymic hormones and their neuroendocrine interactions in treating congenital and acquired immune deficiencies, with specific attention to TB4-Fragment. The article synthesized evidence on how thymic hormones regulate immune function through interactions with the nervous and endocrine systems, and discussed their potential clinical applications in various immunodeficiency conditions. This is a review of preclinical and clinical literature rather than original human clinical research.

[Thymic hormones. Neuroendocrine interactions and clinical use in congenital and acquired immune deficiencies]. Read Post »

Scroll to Top